BR112012012315A2 - composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica - Google Patents
composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêuticaInfo
- Publication number
- BR112012012315A2 BR112012012315A2 BR112012012315A BR112012012315A BR112012012315A2 BR 112012012315 A2 BR112012012315 A2 BR 112012012315A2 BR 112012012315 A BR112012012315 A BR 112012012315A BR 112012012315 A BR112012012315 A BR 112012012315A BR 112012012315 A2 BR112012012315 A2 BR 112012012315A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- dusturium
- anus
- rectum
- alleviating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/1067—Anus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2703MU2009 | 2009-11-23 | ||
| IN2522MU2010 | 2010-09-13 | ||
| PCT/GB2010/002161 WO2011061516A2 (en) | 2009-11-23 | 2010-11-23 | Topical foam composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012012315A2 true BR112012012315A2 (pt) | 2018-10-16 |
Family
ID=43447945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012012315A BR112012012315A2 (pt) | 2009-11-23 | 2010-11-23 | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130202654A1 (pt) |
| EP (1) | EP2503988A2 (pt) |
| JP (1) | JP2013511569A (pt) |
| KR (1) | KR20120099731A (pt) |
| CN (1) | CN102724961A (pt) |
| AU (1) | AU2010320653A1 (pt) |
| BR (1) | BR112012012315A2 (pt) |
| CA (1) | CA2781579A1 (pt) |
| MX (1) | MX2012005882A (pt) |
| NZ (1) | NZ600358A (pt) |
| RU (1) | RU2012126080A (pt) |
| WO (1) | WO2011061516A2 (pt) |
| ZA (1) | ZA201204017B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2522895T3 (es) | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
| ES2810010T3 (es) * | 2014-05-12 | 2021-03-08 | Alfasigma Spa | Preparación y uso de la forma cristalina tau de rifaximina solvatada con DEGME |
| WO2019226571A1 (en) * | 2018-05-19 | 2019-11-28 | Gary Binyamin | Foam formulations and delivery methods to the body |
| CA3136718A1 (en) * | 2019-04-11 | 2020-10-15 | 9 Meters Biopharma, Inc. | Composition and methods for rectal delivery of 4-aapa and 5-asa compounds |
| CN115192955A (zh) * | 2022-08-02 | 2022-10-18 | 九江中船长安消防设备有限公司 | 一种高效的三相泡沫灭火剂及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8909559D0 (en) | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Pharmaceutical compositions |
| IT1243379B (it) | 1990-07-27 | 1994-06-10 | Giuliani Spa | Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico |
| IT1253711B (it) * | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
| IT1264494B1 (it) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
| US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| KR101108439B1 (ko) | 2002-10-25 | 2012-01-31 | 포믹스 리미티드 | 화장료 및 약제용 거품제 |
| US9211259B2 (en) * | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| CA2626208A1 (en) * | 2005-10-24 | 2007-05-03 | Collegium Pharmaceutical, Inc. | Topical pharmaceutical foam composition |
| US8486972B2 (en) * | 2006-01-25 | 2013-07-16 | Insys Therapeutics, Inc. | Sublingual fentanyl spray |
| ES2747259T3 (es) * | 2006-03-09 | 2020-03-10 | Salix Pharmaceuticals Inc | Preparación anti-disfunción rectal de rifaximina |
| JP2008184393A (ja) * | 2007-01-26 | 2008-08-14 | Univ Nihon | アクリルコポリマーとの混合粉砕による難水溶性薬物の溶解性改善及び放出制御型粒子の調製 |
| JP5149585B2 (ja) * | 2007-10-02 | 2013-02-20 | 浜松ホトニクス株式会社 | 微粒子分散液製造方法 |
| CN101502510B (zh) * | 2009-03-19 | 2011-11-09 | 山东京卫制药有限公司 | 一种用于治疗阴道炎症的药物组合物及其制备方法 |
-
2010
- 2010-11-23 AU AU2010320653A patent/AU2010320653A1/en not_active Abandoned
- 2010-11-23 US US13/511,303 patent/US20130202654A1/en not_active Abandoned
- 2010-11-23 NZ NZ600358A patent/NZ600358A/en not_active IP Right Cessation
- 2010-11-23 EP EP10784332.8A patent/EP2503988A2/en not_active Withdrawn
- 2010-11-23 MX MX2012005882A patent/MX2012005882A/es not_active Application Discontinuation
- 2010-11-23 JP JP2012540489A patent/JP2013511569A/ja active Pending
- 2010-11-23 CN CN2010800581423A patent/CN102724961A/zh active Pending
- 2010-11-23 BR BR112012012315A patent/BR112012012315A2/pt not_active IP Right Cessation
- 2010-11-23 WO PCT/GB2010/002161 patent/WO2011061516A2/en active Application Filing
- 2010-11-23 CA CA2781579A patent/CA2781579A1/en not_active Abandoned
- 2010-11-23 RU RU2012126080/15A patent/RU2012126080A/ru unknown
- 2010-11-23 KR KR1020127016201A patent/KR20120099731A/ko not_active Application Discontinuation
-
2012
- 2012-06-01 ZA ZA2012/04017A patent/ZA201204017B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011061516A3 (en) | 2011-11-03 |
| JP2013511569A (ja) | 2013-04-04 |
| MX2012005882A (es) | 2012-10-09 |
| CN102724961A (zh) | 2012-10-10 |
| NZ600358A (en) | 2014-05-30 |
| RU2012126080A (ru) | 2013-12-27 |
| ZA201204017B (en) | 2012-12-27 |
| KR20120099731A (ko) | 2012-09-11 |
| EP2503988A2 (en) | 2012-10-03 |
| WO2011061516A2 (en) | 2011-05-26 |
| CA2781579A1 (en) | 2011-05-26 |
| US20130202654A1 (en) | 2013-08-08 |
| AU2010320653A1 (en) | 2012-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012012316A2 (pt) | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou ânus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de um silicone e dispensador para composição farmacêutica | |
| BR112012012315A2 (pt) | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica | |
| IL244293A0 (en) | Pharmaceutical preparation and method of treatment for emergency contraception | |
| IL205318A0 (en) | Compositions comprising electrochemically altered aqueous fluids and uses thereof for treating inflammation | |
| BR112012008854A2 (pt) | combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| BR112013018953A2 (pt) | composição efervescente na forma sólida para uso em aplicações vaginais para o tratamento de infecções vaginais. | |
| BRPI0821145A2 (pt) | Agente terapêutico para prurido | |
| PT2718318T (pt) | Derivados de oxintomodulina inovadores e composição farmacêutica para tratar a obesidade compreendendo os mesmos | |
| BRPI0912542A2 (pt) | derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas. | |
| BRPI1015006A2 (pt) | uso tópico, periocular, ou intraocular de tocotrienóis para o tratamento de doenças oftálmicas | |
| BRPI0906576A2 (pt) | Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer | |
| GB0719712D0 (en) | Lavatory treatment block compositions with substantive foaming benefits and improved lifespan | |
| BRPI0910780A2 (pt) | uso de antagonistas de opióides para o tratamento da retenção urinária | |
| PT2229369T (pt) | Derivados de 6,7-dialcoxi-quinazolina úteis para tratamento de distúrbios relacionados com o cancro | |
| EP2319539A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR AXIAL MYOPIA | |
| IL216149A (en) | Heterocyclic phenoxymethyl compounds, their pharmaceutical preparations and their use in the preparation of drugs for the treatment of central nervous system disorders | |
| DK2022504T3 (da) | Salve til behandling af hæmorider | |
| BRPI0922367A2 (pt) | enzastaurin para o tratamento de câncer | |
| BRPI0912890A2 (pt) | composição farmacêutica para o tratamento de ejaculação precoce | |
| IL200044A (en) | Tricyclic compounds as modulators of a glucocorticoid receptor and their use in the preparation of drugs for the treatment of diseases | |
| BRPI0914454A2 (pt) | "composição para o tratamento do tecido epitelial" | |
| BRPI0808791A2 (pt) | derivados tricíclicos de isoquinolina para tratamento de obesidade | |
| HK1145137A1 (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| BRPI0810762A2 (pt) | Composição para tratamento da água |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
| B25G | Requested change of headquarter approved |
Owner name: CIPLA LIMITED (IN) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018. |